Trials / Recruiting
RecruitingNCT06223906
A Registry Study of Biomarkers in Heart Valve Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200,000 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2030-01-01
- Completion
- 2030-01-01
- First posted
- 2024-01-25
- Last updated
- 2024-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06223906. Inclusion in this directory is not an endorsement.